UK Interdisciplinary Breast Cancer Symposium 2020

HER2 positive patients with higher than median primary tumour GREM1 expression, have poor relapse free and distant metastasis free survival in comparison to those with lower than median GREM1 expression(p = 0.03 and p < 0.0001 respectively)(see table ) . ................
................